financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Buy Opinion On Shares Of Markel Group Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Buy Opinion On Shares Of Markel Group Inc.
May 2, 2024 9:56 PM

12:30 AM EDT, 05/03/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lift our 12-month target price by $265, to $1,810, valuing MKL shares at 17.4x our '25 operating EPS estimate of $104.25 and at 20.4x our '24 EPS estimate of $88.85 (cut today by $1.80), versus their 5-year average forward multiple of 20.7x and a peer average of 14x. Q1 operating EPS of $21.23 versus $16.08 beat the consensus view of $18.30 but lagged our $24.03 EPS estimate. Results reflected 9% higher operating revenues (versus our 8%-12% growth forecast) on 8% higher premiums (8%-10% estimated), 37% higher investment income (20%-plus), and Markel Ventures revenue growth of 6.5% (5%-10%). We expect operating revenues to rise by 8%-12% in '24 and by 9%-14% in '25 on a continuation of these trends within MKL's diversified business model. Currently trading at 17.7x our '24 operating EPS estimate, we view the shares as undervalued versus historical averages, and see continued attractive insurance growth trends, enhanced by contributions from the Markel Ventures unit, providing the shares with a catalyst.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Raises Opinion On Shares Of Teva To Hold From Sell
Research Alert: CFRA Raises Opinion On Shares Of Teva To Hold From Sell
Nov 6, 2025
11:40 AM EST, 11/06/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We adjust our target to $24 from $13, which implies a 2026 P/E of 8.7x. This is a premium to its five-year historical forward average of 4.7x as we expect...
Research Alert: CFRA Maintans Hold Opinion On Shares Of Arm Holdings
Research Alert: CFRA Maintans Hold Opinion On Shares Of Arm Holdings
Nov 6, 2025
11:15 AM EST, 11/06/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price to $181 from $162, on a P/E of about 65x our CY 2027 EPS estimate of $2.79, which is well above peers given its...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Coca-cola Europacific Partners
Research Alert: CFRA Maintains Hold Opinion On Shares Of Coca-cola Europacific Partners
Nov 6, 2025
01:05 PM EST, 11/06/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price for CCEP is adjusted to USD98 from USD94. This is based on a 2026 P/E of 18.9x, above the industry forward average of 16.7x but broadly...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Howmet Aerospace Inc.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Howmet Aerospace Inc.
Nov 6, 2025
01:05 PM EST, 11/06/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target by $28 to $228, on a P/E multiple of 42.0x our 2027 EPS estimate, which is a premium to HWM's three-year average forward P/E of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved